Budget 2023: 'Amrit Kaal' budget fails to give booster dose for pharma & healthcare
Budget allotted ₹89,160 crore for healthcare sector for FY2024, less than 3% increase from previous year. In FY23, spending on healthcare was only 2.1% of GDP.
pharma sector
February 2023
January 2023
September 2022
August 2022
USFDA inspections to be less disruptive for Indian pharma sector: Report
Indian pharma companies have increasingly de-risked their operations by slowly and steadily increasing sales to non-US markets, says India Ratings and Research.
Budget 2023 may offer Research Linked Incentive scheme for Indian pharma
RLI is expected to provide an extra financial cushion, in addition to the existing R&D sops available to pharmaceutical and biotech companies operating in India.
Surprise! Despite Covid-19 sales, Indian pharma an underperformer
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
Sluggish exports to hit pharma revenue growth: CRISIL
The domestic formulations market is expected to grow 7-9% this fiscal.
